Compare VKTX & QTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VKTX | QTWO |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.1B |
| IPO Year | 2015 | 2014 |
| Metric | VKTX | QTWO |
|---|---|---|
| Price | $30.39 | $61.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 14 |
| Target Price | $87.07 | ★ $99.00 |
| AVG Volume (30 Days) | ★ 3.4M | 590.6K |
| Earning Date | 02-05-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.51 |
| Revenue | N/A | ★ $769,632,000.00 |
| Revenue This Year | N/A | $15.92 |
| Revenue Next Year | N/A | $10.33 |
| P/E Ratio | ★ N/A | $128.70 |
| Revenue Growth | N/A | ★ 13.93 |
| 52 Week Low | $18.92 | $58.57 |
| 52 Week High | $43.15 | $102.07 |
| Indicator | VKTX | QTWO |
|---|---|---|
| Relative Strength Index (RSI) | 38.51 | 29.55 |
| Support Level | $32.42 | $64.78 |
| Resistance Level | $34.99 | $69.36 |
| Average True Range (ATR) | 1.94 | 2.16 |
| MACD | -0.17 | -0.49 |
| Stochastic Oscillator | 13.36 | 7.16 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Q2 Holdings Inc. is a provider of cloud-based virtual banking solutions for regional financial institutions to deliver mobile banking services to retail and commercial end-users who wish to bank anywhere and anytime. Its solutions operate on an integrated tablet-first platform which provides financial institutions a comprehensive view of account holder activity and meets the regulatory and security requirements applicable to the industry. The firm generates revenue from subscription-based arrangements for software offerings. A large majority of the firm's revenue is generated in the United States.